{
    "Trade/Device Name(s)": [
        "IMDx VanR for Abbott m2000"
    ],
    "Submitter Information": "Intelligent Medical Devices, Inc.",
    "510(k) Number": "K123753",
    "Predicate Device Reference 510(k) Number(s)": [
        "K102416"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NIJ",
        "OOI"
    ],
    "Summary Letter Date": "June 13, 2013",
    "Summary Letter Received Date": "June 14, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial susceptibility test powder"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "vanA gene",
        "vanB gene"
    ],
    "Specimen Type(s)": [
        "Perirectal swab",
        "Rectal swab",
        "Stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abbott m2000 System"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Fluorescent probe detection"
    ],
    "Methodologies": [
        "PCR amplification",
        "Qualitative detection of nucleic acids"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for IMDx VanR for Abbott m2000 assay detecting vanA and vanB vancomycin resistance genes in enterococci using real-time PCR.",
    "Indications for Use Summary": "Qualitative detection of vanA and/or vanB vancomycin resistance genes in human perirectal swabs, rectal swabs, or stool specimens to aid in identifying, preventing, and controlling VRE colonization in healthcare settings; not intended for diagnosis or monitoring of infection.",
    "fda_folder": "Microbiology"
}